Literature DB >> 3597378

The insulin receptor. Structural basis for high affinity ligand binding.

M Böni-Schnetzler, W Scott, S M Waugh, E DiBella, P F Pilch.   

Abstract

Treatment of the soluble insulin receptor from human placenta with 1.25 mM dithiothreitol and 75 mM Tris at pH 8.5 results in complete reduction of interhalf disulfide bonds (class 1 disulfides) and dissociation of the tetrameric receptor into the dimeric alpha beta form. The alpha beta receptor halves exhibit a reduced affinity for insulin binding (Böni-Schnetzler, M., Rubin, J. B., and Pilch, P. F. (1986) J. Biol. Chem. 261, 15281-15287). Kinetic experiments reveal that reduction of class 1 disulfides is a faster process than the loss of affinity for ligand, indicating that events subsequent to reduction of interhalf disulfides are responsible for the affinity change. We show that a third class of alpha subunit intrachain disulfides is more susceptible to reduction at pH 7.6 than at pH 8.5 and appears to form part of the ligand binding domain. Reduction of the intrachain disulfide bonds in this part of the alpha subunit leads to a loss of insulin binding. Modification of this putative binding domain by dithiothreitol can be minimized if reduction is carried out at pH 8.5. When the insulin receptor in placental membranes is reduced at pH 8.5, the receptor's affinity for insulin is not changed when binding is measured in the membrane. However, the Kd for insulin binding is reduced 10-fold when alpha beta receptor halves are subsequently solubilized. Scatchard analysis of insulin binding to reduced or intact receptors in the membrane and in soluble form together with sucrose density gradient analysis of soluble receptors suggests that alpha beta receptor halves remain associated in the membrane after reduction, but they are dissociated upon solubilization. We interpret these results to mean that the association of two ligand binding domains, 2 alpha beta receptor halves, is required for the formation of an insulin receptor with high affinity for ligand.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3597378

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Recent developments in the structure, function and regulation of platelet-derived growth factor and its receptors.

Authors:  J Tiesman; A Rizzino
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

2.  Alkylation, reduction, solubilization and enrichment of binding activity do not impair the ability of insulin receptors to convert from a rapid- into a slow-dissociating state.

Authors:  K E Lipson; A A Kolhatkar; D B Donner
Journal:  Biochem J       Date:  1989-05-01       Impact factor: 3.857

3.  High affinity binding sites for proinsulin in human IM-9 lymphoblasts.

Authors:  P M Jehle; M P Lutz; R D Fussgaenger
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

4.  Negative and positive site-site interactions, and their modulation by pH, insulin analogs, and monoclonal antibodies, are preserved in the purified insulin receptor.

Authors:  C C Wang; I D Goldfine; Y Fujita-Yamaguchi; H G Gattner; D Brandenburg; P De Meyts
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

5.  Density-induced down regulation of epidermal growth factor receptors.

Authors:  A Rizzino; P Kazakoff; J Nebelsick
Journal:  In Vitro Cell Dev Biol       Date:  1990-05

6.  Proteolytic generation of constitutive tyrosine kinase activity of the human insulin receptor.

Authors:  J J Hsuan; J Downward; S Clark; M D Waterfield
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

7.  The endogenous functional turkey erythrocyte and rat liver insulin receptor is an alpha 2 beta 2 heterotetrameric complex.

Authors:  J L Treadway; B D Morrison; J A Wemmie; I Frias; T O'Hare; P F Pilch; J E Pessin
Journal:  Biochem J       Date:  1990-10-01       Impact factor: 3.857

8.  The extracellular and transmembrane domains of the γC and interleukin (IL)-13 receptor α1 chains, not their cytoplasmic domains, dictate the nature of signaling responses to IL-4 and IL-13.

Authors:  Nicola M Heller; Xiulan Qi; Franck Gesbert; Achsah D Keegan
Journal:  J Biol Chem       Date:  2012-07-24       Impact factor: 5.157

9.  High-affinity insulin binding: insulin interacts with two receptor ligand binding sites.

Authors:  Linda Whittaker; Caili Hao; Wen Fu; Jonathan Whittaker
Journal:  Biochemistry       Date:  2008-12-02       Impact factor: 3.162

10.  Guanosine nucleotides regulate hormone binding of insulin receptors.

Authors:  E R Mortensen; J Drachman; G Guidotti
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.